Abbott Laboratories Stock

Equities

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:01 2024-05-16 pm EDT 5-day change 1st Jan Change
104.9 USD +0.27% Intraday chart for Abbott Laboratories +0.19% -4.72%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2024 * 41.7B Sales 2025 * 44.75B Capitalization 182B
Net income 2024 * 5.96B Net income 2025 * 7.18B EV / Sales 2024 * 4.51 x
Net Debt 2024 * 5.47B Net cash position 2025 * 640M EV / Sales 2025 * 4.06 x
P/E ratio 2024 *
30.7 x
P/E ratio 2025 *
26.2 x
Employees 114,000
Yield 2024 *
2.07%
Yield 2025 *
2.21%
Free-Float 86.96%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.04%
1 week+0.19%
Current month-1.04%
1 month-3.97%
3 months-8.02%
6 months+4.60%
Current year-4.72%
More quotes
1 week
103.36
Extreme 103.36
105.50
1 month
103.36
Extreme 103.36
108.19
Current year
103.36
Extreme 103.36
121.64
1 year
89.67
Extreme 89.674
121.64
3 years
89.67
Extreme 89.674
142.60
5 years
61.61
Extreme 61.61
142.60
10 years
36.00
Extreme 36
142.60
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 14-12-31
Director of Finance/CFO 51 96-12-31
Chief Tech/Sci/R&D Officer - 89-12-31
Members of the board TitleAgeSince
Director/Board Member 69 17-02-15
Director/Board Member 63 17-06-28
Director/Board Member 65 11-12-08
More insiders
Date Price Change Volume
24-05-16 104.9 +0.27% 8,708,267
24-05-15 104.6 +0.56% 5,443,172
24-05-14 104 -0.73% 7,035,128
24-05-13 104.8 +0.03% 5,459,183
24-05-10 104.7 +0.07% 7,349,729

Delayed Quote Nyse, May 16, 2024 at 04:00 pm EDT

More quotes
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
104.9 USD
Average target price
126.1 USD
Spread / Average Target
+20.28%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW